CAMM Molecular Core awarded $2.8 million from NIAID ACTG Lab Center

CAMM Molecular Core awarded $2.8 million from NIAID ACTG Lab Center to establish a state of the art CLIA lab in the Fitzsimons Innovation Community to support molecular assays for tuberculosis and other bacterial diseases.